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Assessing the Correlation Between SF3B1 Variants and Ring Sideroblasts Percentage in Patients With Myeloid Neoplasm Undergoing Next-Generation Sequencing
Raisa Balbuena-Merle, John Greg Howe, PhD, Karl Hager, PhD, Richard Torres, MD, Henry Rinder, MD, FASCP, Christopher Tormey, MD, FASCP, Alexa Siddon, MD, FASCP; Yale University, New Haven, CT SF3B1 "hotspot" variants have been associated with the presence of ring sideroblasts in patients with myelodysplastic syndrome (MDS). However, it is unclear whether any variant SF3B1 might be associated with an increase in ring sideroblasts across the spectrum of myeloid
